A NEW SCIENCE FIELD

慶應義塾大学ヒト生物学-微生物叢- 量子計算研究センター (Bio2Q)

Keio University Human Biology- Microbiome- Quantum Research Center (Bio2Q)

Integrating Biology, Microbiome and Quantum Computing for Healthy Longevity

News

ANNOUNCEMENT

2025.01.29

Newsletter "Bio2Q Connect" (Vol. 2, Issue 4)

We are delighted to share with you Vol. 2, Issue 4 of WPI-Bio2Q Newsletter "Bio2Q Connect". Major topics of this issue include: New ...

EVENT

2025.01.24

[Seminar] WPI-Bio2Q Open Seminar: Wataru Shihoya, Ph.D.（for Keio Members）

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event only for facul...

EVENT

2025.01.06

The 3rd Keio University WPI-Bio2Q International Symposium [Updated on Jan. 27]

The Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold the 3rd Keio University WPI-Bio2Q International S...

RESEARCH

2025.01.06

[Publication] Advantages of Fixing Spins in Quantum Annealing

Title Advantages of Fixing Spins in Quantum Annealing Authors Tomohiro Hattori [1]; Hirotaka Irie [2]; Tadashi Kadowaki [2],[3]; and ...

SEE ALL NEWS

Mission & Identity of Bio2Q

Human health is maintained by complex interactions between multiple organs. These interactions include the microbiome, which exists on every external surface of the body, and the resulting information is processed and utilized in a coordinated manner.

Our center will develop novel research techniques to understand the interactions between multiple organs and the microbiome and develop methods to apply quantum computing to human biology. Our mission is to forge a new interdisciplinary research area that will lead to groundbreaking progress in elucidating the regulatory mechanisms sustaining human health. In the long term, we will develop new prophylactic/therapeutic approaches to promote healthy longevity.

World leaders in microbiome research, organoid technology, metabolic analysis, neural circuit analysis, and quantum computing

Integration of cutting-edge technologies of the three research core units, the Multidimensional data analysis core, the Homeodynamics mechanistic analysis core, and the Quantum computing core, to promote fusion research

Application of Artificial Intelligence (AI) and quantum computing to further the understanding of human biology

Comprehensive, longitudinal clinical samples related to cancer, diabetes, obesity, neuropsychiatric disorders, developmental disorders, immune disorders, aging, and centenarians

A joint cross-disciplinary graduate English program (STaMP) between the Graduate School of Medicine, Graduate School of Pharmaceutical Sciences, and Graduate School of Science and Technology.

Message from Director

Prof. Kenya Honda

As Japan’s first microbiome research center, Bio2Q aims to understand the interactions between humans and their microbiome at the molecular level. We combine quantum computing with bioanalytical methods to understand such complexity and hope to develop new therapies for diseases that are currently difficult to treat. We are committed to making our organization globally competitive to attract a diverse team of researchers.

Members & Collaboration

Our Team

Bio2Q brings together world-leading experts across multiple life science disciplines, bioinformatics and quantum computing functionally organized into Bio-1 (Multidimensional data analysis), Bio-2 (Homeodynamics mechanistic analysis) and Q (quantum computing) core units.

MEMBERS LIST

Collaborations

Bio2Q is part of the collaborative network of world-leading researchers. Thus, Bio2Q collaborates with researchers from Harvard University, MRC-LMB, Nanyang Technological University, Riken, and Central Institute for Experimental Animals.

Goals of Research

Accumulate multiomics data from humans and model organisms and compile a multidimensional database.

Elucidate the structure and function of microbiome-derived metabolites.

Refine imaging metabolomics and structural biology to promote in situ functional analysis of metabolites in organs and cells.

Develop quantum computing-based algorithms and pipelines to analyze the interactions between multiple organs and microorganisms.

Model the interface between the environment and the human body by advancing organoid technology and animal models and elucidate the mechanisms underlying the conversion of external factors into internal signals.

Leverage connectomics and structural biology to understand the dynamic multiorgan interactions, including gut-brain communication.

Multiorgan
Interactions

Bio 1 Core
Bio 2 Core
Q Core

Education

A joint cross-disciplinary graduate
English program

Bio2Q has established a joint cross-disciplinary graduate English program called STaMP (Science and Technology, and Medicine, Pharmacy) between the Graduate School of Medicine, the Graduate School of Science and Technology, and the Graduate School of Pharmaceutical Sciences. The Bio2Q STaMP program is a “place of resonance” where faculty, researchers, and students from the three graduate schools can directly interact with one another. This enables each graduate student to work with multiple mentors and receive guidance that transcends graduate school boundaries.

STaMP aims to achieve the following:

Shared mentor program
Research internship program
Symposium & retreat led by graduate students
Cross-listed graduate workshops
High school outreach program

Support Bio2Q

Donation
Your generous support will play a significant role in shaping the future of medical research at our center and for the betterment of humanity.

Please get in touch via our administration office if you are considering supporting our research efforts at Bio2Q.

Your Support Allows Us To:

Promote interdisciplinary research activities
Maintain our research environment
Develop research talent
Manage and operate our research center
Contribute to society by sharing research findings and related activities worldwide

Information on Tax Benefits (Donation Deduction)
Donations made to Keio University are considered contributions to specified public interest promotion organizations. This means they qualify for preferential treatment under the Income Tax Act (for individuals) and the Corporation Tax Act (for corporations) in the form of donation deductions or tax deductions. For comprehensive details, please visit the Keio University Office of Fund Raising website.